高级搜索
立即登录 | 免费注册
当前位置 >   首页 (呼吸病学) > 医药资讯 >  药品动态  > 药品资讯内容

在全国范围内自愿召回在售膳食补充剂Libimax

Voluntary nationwide recall of Libimax, a product marketed as a dietary supplement

2009-04-30 【发表评论】
中文 | ENGLISH | 打印| 推荐给好友


ST LOUIS (MD Consult) - Nature & Health Co, located in Brea, Calif., has announced a voluntary nationwide recall of the company's libido supplement product Libimax.

The company has been informed by representatives of the US Food and Drug Administration (FDA) that lab analysis by the FDA of Libimax samples found the product contains tadalafil, an active ingredient of an FDA-approved drug for erectile dysfunction (ED), making Libimax an unapproved drug. The FDA said this poses a threat to consumers because tadalafil may interact with nitrates found in some prescription drugs (such as nitroglycerin) and may lower blood pressure to dangerous levels.

People with diabetes, high blood pressure, high cholesterol, or heart disease often take nitrates. Erectile dysfunction is a common problem in men with these conditions, the FDA said, and they may seek products to enhance sexual performance. Tadalafil may cause adverse effects such as headaches and flushing.

The recalled Libimax is sold as a 1-capsule individual pack or as 10-capsule and 20-capsule plastic bottles in retail stores in California, Georgia, Illinois, Texas, and Ohio. The product label neither states it contains tadalafil nor warns consumers with high blood pressure not to ingest the product.

Consumers who have Libimax should stop using it immediately and contact their physician if they experienced any problem that may be related to taking this product. The public is encouraged to submit a report of any serious adverse events that occur with the use of Libimax to the FDA's MedWatch Adverse Event Reporting program.

Nature & Health Co is committed to providing accurate information about its products and is working with the FDA in the recall process. To date, no illnesses have been reported to the company in connection with this product.

Consumers should return any unused Libimax for a refund of the full purchase price or price for the unused portion to the retail location where it was purchased. They can also contact Nature & Health directly at (714) 257-1800 Monday through Friday, 8 AM to 5 PM, or by email at sales@naturenhealth.com with any questions or to receive further instructions for returning the product.
 

圣路易斯(MD Consult)——位于加利福尼亚州布瑞亚的Nature & Health公司宣布在全国范围内自愿召回性欲膳食补充剂产品Libimax

 

美国食品和药物管理局(FDA)已向该公司发出一份通报,称 FDA实验室分析发现该公司的Libimax含有未经申报的治疗勃起功能障碍(ED)的他达拉非。美国FDA指出这对消费者构成了威胁,因为他达拉非可能会与一些处方药(如硝酸甘油)的硝酸盐发生作用,引起血压下降至危险水平。

 

糖尿病、高血压、高胆固醇或心脏病患者往往会服用硝酸盐类药物。勃起功能障碍是男性常见的问题,他们可能服用性保健品,以提高性功能。他达拉非可能会导致诸如头痛和面红等副作用。

 

被召回Libimax的规格有1粒单独装或每10 粒和20粒塑料瓶装,在加利福尼亚、佐治亚、伊利诺伊、得克萨斯和俄亥俄州的零售商店均有销售。该产品说明书没有说明含有他达拉非,也没有提醒患有高血压的消费者不得使用本品的警告。

 

消费者应立即停止使用Libimax,如果遇到可能涉及到该产品的任何问题应联系本人的医生。鼓励公众对使用Libimax出现的任何严重不良事件向FDAMedWatch不良事件报告项目组报告。

 

网络:请登录MedWatch网站www.fda.gov/medwatch

电话:请拨打1-800-FDA-1088

邮件:请从www.fda.gov/MedWatch/getforms.htm下载已付邮资的FDA3500表格,并寄至MedWatch, FDA, 5600 Fishers Lane, Rockville, MD 20852-9787

传真:请发至1-800-FDA-0178

 

Nature & Health公司保证其提供的产品信息的准确性,目前正在与FDA一道进行产品的召回。迄今为止,该公司此类产品消费者未报告发生任何身体不适。


消费者应在购买处退还未使用的Libimax问题产品,可获得全额退款,使用过的产品则可获得部分退款。消费者如有疑问或需接受进一步的退货指导,请在每周一至周五上午8点到下午5点致电714-257-1800或通过电子邮件sales@naturenhealth.com直接联系Nature & Health公司。


Subjects:
nephrology_urology
学科代码:
泌尿外科学

请登录后发表评论, 点击此处登录。

疾病资源中心  疾病资源中心
 病例分析

摘自:《西氏内科学》,第23

 

患者女性,41岁,主诉右侧刀割样胸痛。数周前,患者首次感觉到疼痛,但最初并未求医。疼痛呈持续性,深吸气不会加重,未伴有咯血或呼吸困难。自诉很少咳嗽,有时咳出肉色粘痰。患者否认发热、寒战、盗汗、体重减轻、胃肠道或泌尿道等其他症状。

医学数据库  医学数据库